Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic expanded, it was clear that effective testing for the presence of neutralizing antibodies in the blood of convalescent patients would be critical for development of plasma-based therapeutic approaches. To address the need f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Richard S., Postnikova, Elena N., Liang, Janie, Gross, Robin, Mazur, Steven, Dixit, Saurabh, Kocher, Gregory, Yu, Shuiqing, Georgia-Clark, Shalamar, Gerhardt, Dawn, Cai, Yingyun, Marron, Lindsay, Lukin, Vladimir V., Holbrook, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151879/
https://www.ncbi.nlm.nih.gov/pubmed/34065987
http://dx.doi.org/10.3390/v13050893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151879/
https://www.ncbi.nlm.nih.gov/pubmed/34065987
http://dx.doi.org/10.3390/v13050893

Ejemplares similares